L3MBTL1 Ligand UNC669 - Product Analysis & Applications

REF #: 3199799
Short description

L3MBTL1 Ligand, UNC669

  • Target: Second MBT (Malignant Brain Tumor) module of ‘chromatin lock’ L3MBTL1
  • Synonyms: L3MBTL1 Ligand, UNC669; 5-Bromo-N-(4-(pyrrolidinyl)piperidinyl)nicotinamide
Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Delivery options
  • 7 Days Return Back Policy
  • 2 Days Cancellation Policy
  • Ship Only

L3MBTL1 Ligand, UNC669

The L3MBTL1 Ligand, UNC669, is a remarkable nicotinamido-pyrrolidine compound specifically designed to target the second MBT module of "chromatin lock" L3MBTL1. L3MBTL1, also known as Malignant Brain Tumor 1 (MBT1), is a chromatin-associated protein that plays a significant role in gene regulation and cell differentiation. The unique structure and properties of UNC669 make it an excellent candidate for research and therapeutic applications in the field of chromatin biology.


  • L3MBTL1 Ligand, UNC669
  • 5-Bromo-N-(4-(pyrrolidinyl)piperidinyl)nicotinamide


The L3MBTL1 Ligand, UNC669, is composed of high-quality and carefully selected ingredients to ensure maximum efficacy and reproducibility in experiments. The key ingredient in UNC669 is a nicotinamido-pyrrolidine compound, which has been synthesized and purified using state-of-the-art techniques. The compound is produced with utmost precision to achieve the desired chemical structure and biological activity.


The composition of L3MBTL1 Ligand, UNC669, is characterized by the presence of a bromo group, a pyrrolidinyl moiety, and a piperidinyl group. These functional groups are strategically positioned to interact with specific amino acid residues in the second MBT module of L3MBTL1, enabling the ligand to bind and modulate the chromatin locking mechanism. The compound also contains a nicotinamide group, which imparts additional chemical stability and pharmacological properties to UNC669.


  • Highly selective: UNC669 exhibits a high degree of selectivity towards the second MBT module of L3MBTL1, allowing for precise targeting and modulation of the chromatin lock mechanism.
  • Potent activity: The unique chemical structure and composition of UNC669 confer potent binding affinity and biological activity towards L3MBTL1, ensuring robust experimental results and potential therapeutic benefits.
  • Reproducibility: UNC669 is produced using sophisticated synthetic techniques and stringent quality control measures, ensuring batch-to-batch consistency and reproducibility of results.
  • Wide range of applications: The L3MBTL1 Ligand, UNC669, is a valuable tool for researchers involved in chromatin biology, epigenetics, and gene regulation studies. It can be employed in various experimental assays, such as binding studies, chromatin immunoprecipitation (ChIP), and functional characterization of L3MBTL1.


The L3MBTL1 Ligand, UNC669, has broad applications in research and development, offering insights into the complex mechanisms of chromatin regulation and potential therapeutic interventions. Some key applications of UNC669 include:

  • Investigation of L3MBTL1 function: UNC669 can be used to dissect the specific roles of L3MBTL1 in gene regulation, cellular differentiation, and other biological processes. By selectively targeting the second MBT module, UNC669 enables researchers to elucidate the functional significance of L3MBTL1 in various cellular contexts.
  • Understanding chromatin locking mechanisms: UNC669 provides a powerful tool for studying the interactions between L3MBTL1 and chromatin. By modulating the chromatin lock function, researchers can gain valuable insights into the dynamic regulation of gene expression and its impact on cellular phenotypes.
  • Epigenetic drug discovery: Given the crucial role of L3MBTL1 in chromatin biology, UNC669 can serve as a starting point for the development of novel therapeutics targeting this pathway. By understanding the binding interactions and structural features of UNC669, researchers can design and optimize new compounds with enhanced potency and selectivity against L3MBTL1.
All categories